...
首页> 外文期刊>Applied psychophysiology and biofeedback >A Multisite Benchmarking Trial of Capnometry Guided Respiratory Intervention for Panic Disorder in Naturalistic Treatment Settings
【24h】

A Multisite Benchmarking Trial of Capnometry Guided Respiratory Intervention for Panic Disorder in Naturalistic Treatment Settings

机译:自然疗法治疗中恐慌症的二氧化碳多导引呼吸干预多站点基准试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Panic disorder (PD) is associated with hyperventilation. The efficacy of a brief respiratory feedback program for PD has been established. The aim of the present study was to expand these results by testing a similar program with more clinically representative patients and settings. Sixty-nine adults with PD received 4 weeks of Capnometry Guided Respiratory Intervention (CGRI) using Freespira, which provides feedback of end-tidal CO2 (PETCO2) and respiration rate (RR), in four non-academic clinical settings. This intervention is delivered via home use following initial training by a clinician and provides remote monitoring of client adherence and progress by the clinician. Outcomes were assessed post-treatment and at 2- and 12-month follow-up. CGRI was associated with an intent-to-treat response rate of 83% and a remission rate of 54%, and large decreases in panic severity. Similar decreases were found in functional impairment and in global illness severity. Gains were largely sustained at follow-up. PETCO2 moved from the slightly hypocapnic range to the normocapnic range. Benchmarking analyses against a previously-published controlled trial showed very similar outcomes, despite substantial differences in sample composition and treatment settings. The present study confirms prior clinical results and lends further support to the viability of CGRI in the treatment of PD.
机译:恐慌症(PD)与换气过度有关。已经建立了针对PD的简短呼吸反馈程序的功效。本研究的目的是通过在临床上更具代表性的患者和环境中测试类似的程序来扩展这些结果。六十九名患有PD的成人在四个非学术性临床环境中使用Freespira接受了为期4周的二氧化碳测定法引导式呼吸干预(CGRI),可提供潮气末二氧化碳(PETCO2)和呼吸速率(RR)的反馈。该干预是在临床医生进行初步培训后通过家庭使用提供的,并由临床医生对客户的依从性和进度进行远程监控。在治疗后以及2个月和12个月的随访中评估结果。 CGRI的意向治疗反应率达83%,缓解率达54%,惊恐严重程度大大降低。在功能障碍和整体疾病严重程度中发现了类似的下降。后续行动中收益基本维持不变。 PETCO2从轻度低碳酸血症的范围转移至正常碳酸血症的范围。尽管样品成分和治疗设置存在很大差异,但针对先前发表的对照试验进行的基​​准分析显示出非常相似的结果。本研究证实了先前的临床结果,并进一步支持了CGRI在PD治疗中的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号